已收盘 07-29 16:00:00 美东时间
0.000
0.00%
Cartesian Therapeutics, a clinical-stage biotech company, announced the granting of inducement awards to three new employees, including options to purchase 26,350 shares with an exercise price of $9.98 under its 2018 Employment Inducement Incentive Award Plan. The options vest 25% on June 2, 2026, followed by three equal annual installments, fully vesting by 2029, with a 10-year term. The company is focused on pioneering cell therapy for autoimmu...
06-03 11:05
Cartesian Therapeutics has啟動其Descartes-08的三期AURORA試驗,這是針對全身性重症肌无力的首款CAR-T療法。首位患者已入組,將評估其療效及安全性。Descartes-08無需預處理化療,適用於門診治療。該療法已在二期研究中展示出持久的應答,平均MG-ADL評分改善顯著。試驗將隨機對照,規模約100例患者,主要終點為三個月時的評分改善情況。公司หวัง藉此改進現有的MG治療方案,提供更安全、持久的選擇。
05-30 11:00
Amur Minerals ( ($GB:CRTX) ) has issued an update. CRISM Therapeutics Corporati...
04-07 18:53
Amur Minerals (GB:CRTX) has released an update. CRISM Therapeutics Corporation ...
2024-09-02 15:24
Amur Minerals (GB:CRTX) has released an update. CRISM Therapeutics Corporation ...
2024-07-03 23:50
Netflix (NASDAQ:NFLX), Walt Disney (NYSE:DIS) and other streaming services were in the spotlight on Tuesday after a Canadian government agency unveiled a new funding contribution targeted at streaming...
2024-06-04 23:48
Cortexyme (NASDAQ:CRTX – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCB – Get...
2023-04-13 04:42
Cortexyme (NASDAQ:CRTX – Get Rating) and Acumen Pharmaceuticals (NASDAQ:ABOS – ...
2023-02-23 15:03
转自:新康界 2022年,生物医药指数(XBI)全年下跌25.87%,最深跌幅达45.13%,不少生物医药企业的市值出现50%以上的下跌,而医药行业的并购却远比...
2023-02-14 17:17
Moderna (NASDAQ:MRNA – Get Rating) and Cortexyme (NASDAQ:CRTX – Get Rating) are...
2022-07-16 15:12